1.      Sideris V., Karagouni E., Papadopoulou G., Garifallou A. & Dotsika E. Canine visceral leishmaniasis in the great Athens Area, Greece.  Parasite, 1996, 3 ,125-130.

 

2.      Spiliotis T., A. Tsirogianni, P. Pipis, C. Pantelidaki, E. Dotsika, D. Vlachopoulos, M. Anagnostopoulou, M. Fameli, A. Tassidou, D. Anagnostou, O. Paniara, I. Economidou, and G. Saroglou (1997). A case of autoimmune inflammatory connective tissue disease and leishmaniasis. Hell Rheumatol, 8(4), 283-289.

 

3.      Papadopoulou G., E. Karagouni and E. Dotsika (1998). ISCOMs vaccine against experimental leishmaniasis.Vaccine 16, No 9/10 pp. 885-892.

 

4.      Sideris, V., G. Papadopoulou, E. Dotsika and E. Karagouni. (1999). Asymptomatic canine leishmaniasis in the greater Athens area, Greece. European J. of Epidemiology 15, 271-276.

 

5.      Α. Bisti, G. Konidou, F. Papageorgiou, G. Milon, J. Boelart and K. Soteriadou (2000). Iron modulation of experimental leishmaniasis. J. Clin. Virol. 16, 83

 

6.      S. Bisti, G. Konidou, F. Papageorgiou, G. Milon, J. Boelart and K. Soteriadou (2000). The outcome of  Leishmania major experimental infection in BALB/C mice can be modulated by endogenously delivered iron. Eur. J. Immunol. 30,3732-3740

 

7.      J. Boelaert, R. Appelberg, M. Gomes, E. Blasi, R. Mazzolla, J. Grosset, N. Lounis, K. Soteriadou, M. Thiakaki, D. Taramelli, C. Tognazioli (2001). Experimental results on chloroquine and AIDS-opportunists. JAIDS Hum. Retroviruses. 26,300-301

 

8.      F. Papageorgiou and K. Soteriadou (2002). Expression of a novel Leishmania gene encoding for an histone H1-like protein in L.major modulates Leishmania infectivity in vitro. Infect. Immun. (In press)